Sr. Director, Computational Chemistry
Cogent Biosciences
Senior Director of Computational Chemistry & Scientific Computing with 20+ years of experience advancing drug discovery through Structure-Based Drug Design, Virtual Screening, QSAR, and FEP+ simulations. Proven track record in delivering impactful therapies across oncology, immunology, and inflammation.
Key Contributions:
Co-inventor and discovery team member for Ruxolitinib (Jakafi®/Jakavi®/Opzelura®), Baricitinib (Olumiant®), Capmatinib (Tabrecta®), and Pemigatinib (Pemazyre®).
Discovery team member for several clinical candidates, including Itacitinib (JAK-1) and INCB057643 (BRD-4).
Co-inventor on 15+ patents and co-author on 20+ scientific publications.
Passionate about integrating computational insights with medicinal chemistry and structural biology to accelerate innovation and bring transformative therapies to patients.
Specialties: Computational Chemistry | Drug Design | Cheminformatics | Oncology & Immunology Drug Discovery | Scientific Computing Leadership
